Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022-Reference-Cited by-同舟云学术

Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022

Published:2023-06-29 Issue:10 Volume:28 Page:1259-1297
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Muto Satoru,Matsubara Takeshi^ORCID,Inoue Takamitsu,Kitamura Hiroshi,Yamamoto Kazuhiro,Ishii Taisuke,Yazawa Masahiko,Yamamoto Ryohei,Okada Naoto,Mori Kiyoshi,Yamada Hiroyuki,Kuwabara Takashige,Yonezawa Atsushi,Fujimaru Takuya,Kawano Haruna,Yokoi Hideki,Doi Kent,Hoshino Junichi,Yanagita Motoko

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s10147-023-02372-4.pdf

Reference294 articles.

1. Japanese Society of Nephrology (2018) Evidence-based Clinical Practice Guideline for CKD 2018, Tokyo-igakusha. https://cdn.jsn.or.jp/data/CKD2018.pdf

2. GBD Chronic Kidney Disease Collaboration (2020) Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395:709–733

3. Rosner MH, Perazella MA (2017) Acute kidney injury in patients with cancer. N Engl J Med 376:1770–1781

4. Chawla LS, Eggers PW, Star RA et al (2014) Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med 371:58–66

5. Launay-Vacher V, Oudard S, Janus N et al (2007) Prevalence of renal insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study. Cancer 110:1376–1384

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bevacizumab-Induced Nephropathy Presenting as Crescentic Glomerulopathy;Cureus;2023-11-14

2. Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022;Clinical and Experimental Nephrology;2023-10-25

3. Chapter 3: Management of kidney injury caused by cancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022;International Journal of Clinical Oncology;2023-07-16

4. Chapter 4: CKD treatment in cancer survivors, from Clinical Practice Guidelines for the Management of Kidney Injury During Anticancer Drug Therapy 2022;International Journal of Clinical Oncology;2023-07-07